Unknown × Interventional × Adenocarcinoma Of Esophagus × Clear all RICE
Phase 2 Unknown
56 enrolled
Utility and Usability of ActivSightâ„¢ Laser Speckle Imaging in Visualization of Tissue Perfusion and Blood Flow During Esophageal Surgery in Humans
Phase NA Unknown
70 enrolled
FOLFOX-6 Induction Chemotherapy Followed by Esophagectomy and Post-operative Chemoradiotherapy in Patients With Esophageal Adenocarcinoma
Phase 2 Unknown
63 enrolled
SENSITIVE
Phase NA Unknown
60 enrolled
ICONIC
Phase 2 Unknown
44 enrolled
RiME
Phase 1/2 Unknown
34 enrolled
ESOGUARDBE2
Phase NA Unknown
470 enrolled
A Multi-center, Single-arm, Open, Phase I/IIa Clinical Trial to Evaluate the Efficacy and Safety of EBViNT Cell (EBV Specific Autologous CD8+ T Cell) in Patients With Treatment Failed Epstein Barr Virus (EBV)-Positive Malignancies
Phase 1/2 Unknown
72 enrolled
ChemoFit
Phase NA Unknown
40 enrolled
Pre-EMPT
Phase NA Unknown
66 enrolled
Endoscopy Every 2 Years or Only as Needed in Monitoring Patients With Barrett Esophagus
Phase NA Unknown
3,400 enrolled
Clinical Study of Time Optimizing of Endoscopic Photodynamic Therapy on Esophageal and/or Gastric Cardiac Cancer
Phase 3 Unknown
40 enrolled
Liposomal Doxorubicin in Treating Patients With Advanced Stomach Cancer
Phase 2 Unknown
Tethered Capsule Endoscope in Screening Participants for Barrett Esophagus
Phase 1/2 Unknown
50 enrolled
Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Cancer of the Stomach or Esophagus
Phase 2 Unknown
LMB-9 Immunotoxin in Treating Patients With Advanced Pancreatic, Esophageal, Stomach, Colon, or Rectal Cancer
Phase 1 Unknown
50 enrolled
Nitrocamptothecin in Treating Patients With Locally Advanced or Metastatic Stomach Cancer That Cannot Be Removed During Surgery
Phase 2 Unknown
Combination Chemotherapy in Treating Patients With Esophageal Cancer
Phase 3 Unknown
1,300 enrolled
Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus
Phase 3 Unknown
326 enrolled
Cisplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients With Esophageal Cancer
Phase 2/3 Unknown
259 enrolled
Paclitaxel in Treating Patients With Metastatic, Recurrent, or Unresectable Cancer of the Esophagus
Phase 2 Unknown
100 enrolled
Endoesophageal Cryotherapy For Ablating Barrett's Esophagus and Early Stage Esophageal Cancer
Phase 4 Unknown
100 enrolled